Send by RTT News

In corporate news, Pfizer Inc. (PFE) and King Pharmaceuticals Inc. (KG) announced a definitive merger agreement, with Pfizer agreeing to purchase King for [...]

12 Oct 2010 Pfizer to Acquire King Pharmaceuticals, Inc. -- Will advance Pfizer's strategic objectives by strengthening its position within the rapidly [...]

12 Oct 2010 NEW YORK (MarketWatch) -- Pfizer Inc said Tuesday that it is buying fellow drug maker King Pharmaceuticals for $3.6 billion, or about a 40% [...]

12 Oct 2010 With King in its fold, Pfizer -- which makes Lyrica and Celebrex -- believes it can build an industry-leading portfolio of pain relievers. [...]

12 Oct 2010 NEW YORK (Reuters) - Pfizer Inc, the world's biggest drugmaker, has agreed to buy King Pharmaceuticals Inc for $3.6 billion, expanding its [...]

5 Aug 2008 Call-option trading in King was the busiest since September and its shares rose to a seven-month high on speculation Pfizer will buy the [...]

12 Oct 2010 Pfizer Inc reached a deal to buy drugmaker King Pharmaceuticals Inc for $3.6 billion in cash, aiming to boost revenue before it loses patent [...]

Both Pfizer and King were not immediately available for comment. King's top two drugs are Altace, a treatment for high blood pressure and the muscle relaxer Skelaxin. [...]

Send by Wall Street Journal

Pfizer Inc. (PFE) said it will buy King Pharmaceuticals for $3.6 billion, the latest move by a big drug company to swallow up a rival as the industry faces [...]

In addition, Zacks Equity Research provides analysis on Pfizer King Pharmaceuticals' (NYSE: KG) fourth quarter earnings of $0.23 were a penny shy of the Zacks Consensus [...]

King Pharmaceuticals Goes Volcanic Pfizer agreed on Tuesday to buy King Pharmaceuticals, a maker of pain medications, for $3.6 billion in cash, in the drug maker's first major deal since its blockbuster purchase of Wyeth last year. [...]

Send by Insurance

Deal Profile: Pfizer to Acquire King Pharmaceuticals. about -1 years ago - No comments. Pfizer agreed to buy pain-drug maker King Pharmaceuticals for $3.6 billion in cash. Go to Source [...]

The official website for the Dr. Martin Luther King, Jr. National Memorial Foundation. To commemorate the life and work of Dr. Martin Luther King, Jr. by leading a [...]

Send by Untreatableonline

Pfizer has taken a giant step by buying King Pharmaceuticals for $3.6 billion in cash. The sale broke down to $14.25 per share and it enables Pfizer to become a dominate player in the pain medication realm. A cool thing about the King [...]

anewsonline: According to the internet media, King Pharmaceuticals, a maker of pain medications, for $3.6 billion in cash, in the drug maker's first major deal since its blockbuster purchase o. [...]

Send by marketmaker

Pfizer Inc. reached a deal to buy drugmaker King Pharmaceuticals Inc for US$3.6-billion in cash, aiming to boost revenue before it loses patent protection on some of its top-selling treatments. Original article · Add new comment [...]

Send by John Carroll

Just two years after swallowing up Alpharma in a $1.6 billion takeover, King Pharmaceuticals is handing over the keys to Pfizer after signing off on a $3.6 billion buyout offer. Pfizer agreed to pay $14.25 a share for King, [...]

The company is heavily involved in making pain drugs. Pfizer Inc., the world's largest pharmaceutical company by revenue, said Tuesday it will buy pain drug maker King Pharmaceuticals Inc. for $3.6 billion in cash. [...]

Send by Ritu Biswas

King Pharmaceuticals Inc. (NYSE: KG) – In a recent press release, King Pharmaceuticals have announced that they would enter into a definitive merger agreement with where Pfizer will acquire King for $ 3.6 million in cash which [...]

Send by newsroom

Pfizer Inc.(NYSE: PFE) and King Pharmaceuticals, Inc. (NYSE: KG) today announced that they have entered into a definitive merger agreement. Under the terms of the agreement, Pfizer will acquire King, a diversified specialty [...]

Pfizer's pain products contain Lyrica and Celebrex. King will result in Avinza, the Flector Patch and the just launched Embeda, the initially standard opioid pain product proposed to discourage abuse. King has other abuse-strong pain [...]

Send by Benzinga

Pfizer Inc (NYSE: PFE) has announced its plans to buy King Pharmaceuticals (NYSE: KG) for $3.6 billion, or $14.25 per share in cash, representing a 40% [...]

Pfizer Inc., the world's largest pharmaceutical company by revenue, said Tuesday it will buy pain drug maker King Pharmaceuticals Inc. for $3.6 billion in cash [...]

Send by Edna

AFPPfizer to Buy King Pharmaceuticals for $3.6 BillionNew York TimesPfizer agreed on Tuesday to buy King Pharmaceuticals, a maker of pain medication, for $ [...]

Send by MarketWatch

King Pharmaceuticals (NYSE:KG) rallied 39% in premarket action. The Bristol, Tenn., drug maker will be acquired for $14.25 a share by Pfizer Inc. (NYSE:PFE) [...]